Voyager Therapeutics (VYGR) Times Interest Earned (2014 - 2026)
Voyager Therapeutics (VYGR) reported Times Interest Earned of -$0.75 for Q1 2026, up 96.85% on a YoY basis from -$0.38 in Q1 2025, and down 266.16% sequentially from -$0.21 in Q4 2025.
Voyager Therapeutics (VYGR) Times Interest Earned (2014 - 2026) Analysis & Trends
Voyager Therapeutics (VYGR) has 13 years of Times Interest Earned data on file, last reported at -$0.75 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned rose 96.85% year-over-year to -$0.75; the trailing twelve-month figure through Mar 2026 stood at -$3.17 (up 95.47% YoY), and the FY2025 full-year result was -$0.91, down 15.28% from the prior year.
- Times Interest Earned retreated to -$0.75 in Q1 2026, from -$0.21 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $11.56 in Q1 2023 to a low of -$269.92 in Q4 2022.
- A 5-year average of -$19.46 and a median of -$1.58 in 2024 frame the typical range for Times Interest Earned.
- Peak annual rise in Times Interest Earned reached 691.06% in 2022, while the deepest fall reached 509285.13% in 2022.
- Tracing VYGR's Times Interest Earned over 5 years: stood at -$269.92 in 2022, then soared by 100.24% to $0.65 in 2023, then plunged by 4778.14% to -$30.61 in 2024, then jumped by 99.33% to -$0.21 in 2025, then sank by 266.16% to -$0.75 in 2026.
- Business Quant data shows VYGR's Times Interest Earned at -$0.75 in Q1 2026, -$0.21 in Q4 2025, and -$3.83 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Voyager Therapeutics | 184.74 Mn | 43.26 Mn | - | -0.75 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.75 |
| Dec 31, 2025 | -0.21 |
| Sep 30, 2025 | -3.83 |
| Jun 30, 2025 | -0.77 |
| Mar 31, 2025 | -23.89 |
| Dec 31, 2024 | -30.61 |
| Sep 30, 2024 | -3.67 |
| Jun 30, 2024 | -1.58 |
| Mar 31, 2024 | -0.91 |
| Dec 31, 2023 | 0.65 |
| Sep 30, 2023 | -3.16 |
| Jun 30, 2023 | -0.85 |
| Mar 31, 2023 | 11.56 |
| Dec 31, 2022 | -269.92 |
| Sep 30, 2022 | 2.54 |
| Jun 30, 2022 | -3.27 |
| Mar 31, 2022 | -2.12 |
| Dec 31, 2021 | 0.05 |
| Sep 30, 2021 | -0.43 |
| Jun 30, 2021 | -2.02 |